WDB Medical Data (WDBMD), a US subsidiary of WDB Holdings Co, has acquired DZS Clinical Services. WDBMD is a global provider of contract research organization (CRO) and R&D services to the biopharmaceutical and medical device industry.

The acquisition with bolster the company’s full-service CRO capabilities and provide more comprehensive and global services to US companies with coverage in Europe and Japan. Services include clinical development and clinical operations support, data management, statistical services, medical writing, pharmacovigilance and regulatory affairs in addition to access to a medical call center. The acquisition includes all resources and processes, allowing a seamless transfer and ensuring no interruption for customers.

“This acquisition and the addition of Greg Ambra and the DZS operations team complement our company and further our goal to provide even greater flexibility and affordability to more businesses and institutions worldwide,” said Norifumi Ninokata, President and CEO of WDBMD.

“Access to WDBMD’s expertise and global resources will increase our capacity and allow us to offer a broader range of services to our clients,” said Greg Ambra, President of DZS Clinical Services.